Propranolol LA
Phase 3Small molecule
Propranolol LA is one of 62 small molecule programs targeting Shoulder pain. It is currently in Phase 3.
2
Indications
3
Total Trials
0
Active Trials
61
Competitors
Pipeline
Status by Indication[3][1]
Competition
Competitive Landscape
357 competitors in Migraine
#DrugCompanyPhaseTrials
1Propranolol LA
MMetroHealth Medical Center
Phase 3
Bayer Aspirin
BayerPreclinical
Savella
AbbViePreclinical
Cervidil
PfizerPreclinical
Botox
RRevance Therapeutics, Inc.
Preclinical
Adempas
BayerPreclinical
Viagra
VViatris Specialty LLC
Preclinical
Nitrostat
VViatris Specialty LLC
Preclinical
Vibramycin
PPfizer's Upjohn has merged with Mylan to form Viatris Inc.
Preclinical
Botulinum Toxin a
GSKPreclinical
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Trials by Indication[1]
Beta-blocker Therapy1 trial
Shoulder pain1 trial
Biopsychosocial Influence on Shoulder Pain
Completed·—·Phase 2·NCT02620579·264 enrolled
Sources
References
- [1]
- [2]
- [3]Open Targets Platform — Drug–disease associations for Propranolol LA. EMBL-EBI & Wellcome Sanger Institute.
- [4]
Details
Drug Info
Quick Facts
- Modality
- Small molecule[2]
- Highest Phase
- Phase 3[1]
- Company
- MMetroHealth Medical Center